+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Particle Therapy Market - Global Forecast 2026-2032- Product Image
Particle Therapy Market - Global Forecast 2026-2032- Product Image
New

Particle Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674447
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The particle therapy market is undergoing a fundamental transformation, driven by recent clinical, technological, and operational advances that are reshaping oncology strategies for providers, manufacturers, and investors. The sector is rapidly expanding its clinical and commercial footprint, making strategic intelligence essential for informed capital and procurement decisions.

Market Snapshot: Particle Therapy Market Growth

The Particle Therapy Market grew from USD 1.16 billion in 2025 to USD 1.26 billion in 2026. It is expected to continue growing at a CAGR of 8.88%, reaching USD 2.11 billion by 2032. This growth reflects sustained momentum as particle therapy shifts from a specialized innovation to a critical modality in advanced cancer care. Robust clinical demand, technical refinements, and evolving operational models position the particle therapy market for continued expansion and new market entrants.

Scope & Segmentation

  • Therapy Modalities: Proton therapy and heavy ion therapy, each with distinct clinical utility and infrastructure requirements.
  • Core System Components: Cyclotron and synchrotron accelerators, treatment delivery systems, and beam transport subsystems such as beam monitors, bending magnets, and collimators.
  • System Architectures: Multi-room platforms for high-throughput clinical settings, as well as single-room systems designed for community and specialty clinics.
  • Clinical Applications: Wide-ranging use across pediatric oncology, head and neck cancer, lung cancer, breast cancer, and prostate cancer indications.
  • End-User Profiles: Hospitals, research institutes, and specialty cancer centers. Distinct procurement and operational strategies based on public versus private sector needs.
  • Geographical Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific—each with unique policy, reimbursement, and clinical implementation drivers.

Key Takeaways for Stakeholders

  • Recent advancements in beam targeting, digital planning, and compact system architecture have lowered deployment barriers and enabled broader application in diverse healthcare settings.
  • Expanding clinical evidence for indications such as pediatric cancers and radioresistant tumors supports earlier integration of particle therapy within multi-disciplinary care pathways.
  • Operational efficiency is being enhanced by networked clinics, modular designs, and increased automation in workflow, which support scalable investment and greater patient access.
  • Regional differences in regulatory frameworks, financing models, and workforce development programs are shaping adoption curves and service models worldwide.
  • Vendor strategies increasingly prioritize after-sales service, integrated digital ecosystems, and partnerships with clinical leaders to create competitive differentiation and align with evolving customer requirements.
  • Collaboration between providers, manufacturers, and payers is critical to define evidence thresholds, streamline market access, and ensure sustainable integration of particle therapy into mainstream oncology.

Tariff Impact: Navigating U.S. Trade Adjustments

As a result of the United States tariff changes announced in 2025, stakeholders in the particle therapy ecosystem are reassessing procurement and supply chain strategies. These adjustments have raised cost and logistical complexity for equipment importation and cross-border servicing, impacting vendors reliant on global supplier networks. Health systems and integrators are responding with a shift toward localized component sourcing, modular system designs, and diversified supplier bases, all aimed at minimizing trade-related risks and maintaining operational resilience.

Methodology & Data Sources

Primary research for this analysis included interviews with clinical leaders, system integrators, capital planners, and manufacturing executives. Secondary data sources encompassed peer-reviewed literature, public regulatory documentation, technical specifications, and procurement records. Triangulation of these inputs, combined with expert validation, supports the reliability and actionability of all insights presented.

Why This Report Matters

  • Provides senior decision-makers with a structured evaluation of technology trends, supply chain challenges, and clinical adoption pathways in the particle therapy market.
  • Clarifies strategic options for investment, procurement, and partnership across diverse organizational contexts and global healthcare systems.
  • Enables effective alignment of technology development, clinical research, and operational planning to achieve accelerated, risk-mitigated market adoption.

Conclusion

Particle therapy is at a pivotal juncture where integrated strategies, resilient supply chains, and cross-sector collaboration will shape the delivery of clinical and commercial value. Stakeholders that prioritize modularity, partnerships, and service excellence will be best positioned for future success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Particle Therapy Market, by Therapy Type
8.1. Heavy Ion Therapy
8.2. Proton Therapy
9. Particle Therapy Market, by Components
9.1. Beam Transport System Components
9.1.1. Beam Monitor
9.1.2. Bending Magnets
9.1.3. Collimators
9.2. Cyclotrons & Synchrotrons Accelerators
9.3. Treatment Delivery Systems
10. Particle Therapy Market, by System
10.1. Multi-Room Systems
10.2. Single-Room Systems
11. Particle Therapy Market, by Application Area
11.1. Breast Cancer
11.2. Head And Neck Cancer
11.3. Lung Cancer
11.4. Pediatric Cancer
11.5. Prostate Cancer
12. Particle Therapy Market, by End User
12.1. Hospitals
12.1.1. Private Hospitals
12.1.2. Public Hospitals
12.2. Research Institutions
12.3. Specialty Clinics
12.3.1. Oncology Clinics
12.3.2. Radiotherapy Centers
13. Particle Therapy Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Particle Therapy Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Particle Therapy Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Particle Therapy Market
17. China Particle Therapy Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. B dot Medical Inc.
18.6. C-Rad AB
18.7. Elekta AB
18.8. Hitachi, Ltd.
18.9. Ion Beam Applications S.A
18.10. Koninklijke Philips N.V.
18.11. Leybold by Atlas Copco Group
18.12. Mevion Medical Systems
18.13. Optivus Proton Therapy, Inc.
18.14. P-Cure Ltd
18.15. ProTom International Holding Corporation
18.16. Provision Healthcare, LLC
18.17. PTW Freiburg GmbH
18.18. SAH Global LLC
18.19. Shanghai APACTRON Particle Equipment Co., Ltd.
18.20. Shinva Medical Instrument Co., Ltd.
18.21. Siemens Healthineers AG
18.22. Stantec Inc.
18.23. Sumitomo Heavy Industries, Ltd.
18.24. Sun Nuclear Corporation by Mirion Technologies
18.25. Toshiba Corporation
18.26. Xstrahl Ltd.
List of Figures
FIGURE 1. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PARTICLE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PARTICLE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM MONITOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM MONITOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BEAM MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BENDING MAGNETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BENDING MAGNETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BENDING MAGNETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COLLIMATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COLLIMATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COLLIMATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS & SYNCHROTRONS ACCELERATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS & SYNCHROTRONS ACCELERATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS & SYNCHROTRONS ACCELERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PARTICLE THERAPY MARKET SIZE, BY TREATMENT DELIVERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PARTICLE THERAPY MARKET SIZE, BY TREATMENT DELIVERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PARTICLE THERAPY MARKET SIZE, BY TREATMENT DELIVERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD AND NECK CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD AND NECK CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD AND NECK CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PARTICLE THERAPY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PARTICLE THERAPY MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PARTICLE THERAPY MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RADIOTHERAPY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RADIOTHERAPY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PARTICLE THERAPY MARKET SIZE, BY RADIOTHERAPY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 113. EUROPE PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 116. EUROPE PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 117. EUROPE PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 118. EUROPE PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 119. EUROPE PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 131. AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 133. AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 134. AFRICA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 135. AFRICA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 136. AFRICA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 137. AFRICA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. AFRICA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 139. AFRICA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL PARTICLE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. ASEAN PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. ASEAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 152. ASEAN PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 153. ASEAN PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 154. ASEAN PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 155. ASEAN PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 156. ASEAN PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. ASEAN PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 158. ASEAN PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 159. GCC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GCC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 161. GCC PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 162. GCC PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 163. GCC PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 164. GCC PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 165. GCC PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. GCC PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 167. GCC PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 177. BRICS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. BRICS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 179. BRICS PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 180. BRICS PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 181. BRICS PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 182. BRICS PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 183. BRICS PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. BRICS PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 185. BRICS PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 186. G7 PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. G7 PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 188. G7 PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 189. G7 PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 190. G7 PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 191. G7 PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 192. G7 PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. G7 PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 194. G7 PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 195. NATO PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. NATO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 197. NATO PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 198. NATO PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 199. NATO PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 200. NATO PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 201. NATO PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. NATO PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 203. NATO PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES PARTICLE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 214. CHINA PARTICLE THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 216. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
TABLE 217. CHINA PARTICLE THERAPY MARKET SIZE, BY BEAM TRANSPORT SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
TABLE 218. CHINA PARTICLE THERAPY MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
TABLE 219. CHINA PARTICLE THERAPY MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 220. CHINA PARTICLE THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. CHINA PARTICLE THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 222. CHINA PARTICLE THERAPY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Particle Therapy market report include:
  • B dot Medical Inc.
  • C-Rad AB
  • Elekta AB
  • Hitachi, Ltd.
  • Ion Beam Applications S.A
  • Koninklijke Philips N.V.
  • Leybold by Atlas Copco Group
  • Mevion Medical Systems
  • Optivus Proton Therapy, Inc.
  • P-Cure Ltd
  • ProTom International Holding Corporation
  • Provision Healthcare, LLC
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shanghai APACTRON Particle Equipment Co., Ltd.
  • Shinva Medical Instrument Co., Ltd.
  • Siemens Healthineers AG
  • Stantec Inc.
  • Sumitomo Heavy Industries, Ltd.
  • Sun Nuclear Corporation by Mirion Technologies
  • Toshiba Corporation
  • Xstrahl Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.26 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.11 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Particle Therapy Market Report and Forecast 2025-2034 - Product Image

Particle Therapy Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Particle Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Particle Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Particle Therapy Market Report 2025 - Product Image

Particle Therapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Particle Therapy - Global Strategic Business Report - Product Image

Particle Therapy - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Particle Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Particle Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Particle Therapy Market

Particle therapy is a type of radiation therapy used to treat cancer. It uses beams of protons or other particles to deliver a precise dose of radiation to the tumor, minimizing damage to surrounding healthy tissue. This type of therapy is particularly useful for treating tumors located near sensitive organs, such as the brain, spinal cord, and eyes. It is also used to treat tumors that are difficult to reach with traditional radiation therapy. Particle therapy is becoming increasingly popular in the oncology drugs market, as it offers a more targeted approach to treating cancer. It is also associated with fewer side effects than traditional radiation therapy, making it a more attractive option for patients. Some of the companies in the particle therapy market include Varian Medical Systems, Elekta, IBA, Hitachi, and ProTom International. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.